Sep 25 |
Editas Medicine: A Risk/Reward Worth Considering
|
Sep 17 |
Editas Medicine, Inc. (EDIT) 2024 Cantor Global Healthcare Conference (Transcript)
|
Sep 17 |
Where Editas Medicine Stands With Analysts
|
Sep 6 |
Editas (EDIT) Down 17% Since Last Earnings Report: Can It Rebound?
|
Sep 6 |
Editas Medicine, Inc. (EDIT) Presents at Wells Fargo 2024 Healthcare Conference (Transcript)
|
Sep 4 |
Editas Medicine, Inc. (EDIT) Presents at Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)
|
Aug 28 |
Editas Medicine to Participate in Upcoming Investor Conferences
|
Aug 15 |
We're Keeping An Eye On Editas Medicine's (NASDAQ:EDIT) Cash Burn Rate
|
Aug 8 |
BofA upgrades Editas to buy, cites reni-cel progress
|
Aug 8 |
Editas (EDIT) Q2 Earnings & Revenues Miss Estimates, Stock Down
|